Mydecine Innovations Group Inc.
Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.
Mydecine Innovations Group Inc. (MYCO)
Le 2 juin/June 2020
NewLeaf Brands Inc. has announced a name and symbol change to Mydecine Innovations Group Inc. (MYCO).
Shares will begin trading under the new name and symbol on June 5, 2020.
Disclosure documents are available at www.thecse.com
Please note that all open orders will be cancelled at the end of business on June 4, 2020. Dealers are reminded to re-enter their orders.